A Study of TQB3454 Tablets in Patients With Blood Tumors

Clinical trial NCT06218771 · UNKNOWN

Trial details

NCT number: NCT06218771
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2023-07-10
Primary completion: 2025-06-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.